
Monday, February 22, 2021 7:12:45 PM
“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Liked By
Spread the love. Be the first to like this post!
Recent ICPT News
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 03/23/2023 08:02:16 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 03/16/2023 08:08:17 PM
- Intercept Says FDA Sets AdCom Meeting on Obeticholic Acid • Dow Jones News • 03/10/2023 03:05:00 PM
- Intercept Announces FDA Advisory Committee Meeting Date for Obeticholic Acid as a Treatment for Pre-Cirrhotic Liver Fibrosis due to NASH • GlobeNewswire Inc. • 03/10/2023 02:05:00 PM
- Intercept Pharmaceuticals to Conduct One-on-One Meetings with Investors at the Barclays Global Healthcare Conference March 14, 2023 • GlobeNewswire Inc. • 03/09/2023 01:00:00 PM
- Annual Report (10-k) • Edgar (US Regulatory) • 03/02/2023 09:33:43 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 03/02/2023 12:06:06 PM
- Intercept Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Updates; Issues 2023 Financial Guidance • GlobeNewswire Inc. • 03/02/2023 12:00:00 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 02/27/2023 01:01:09 PM
- Intercept Pharmaceuticals to Participate in Cowen’s 43rd Annual Health Care Conference on March 7, 2023 • GlobeNewswire Inc. • 02/27/2023 01:00:00 PM
- Intercept to Announce Fourth Quarter and Full Year 2022 Financial Results on March 2, 2023 • GlobeNewswire Inc. • 02/23/2023 01:00:00 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 02/21/2023 01:01:29 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 02/16/2023 09:03:54 PM
- Amended Statement of Ownership (sc 13g/a) • Edgar (US Regulatory) • 02/14/2023 09:03:34 PM
- Amended Statement of Ownership (sc 13g/a) • Edgar (US Regulatory) • 02/09/2023 04:49:43 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 02/03/2023 09:02:33 PM
- Amended Statement of Ownership (sc 13g/a) • Edgar (US Regulatory) • 02/02/2023 05:26:01 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 01/31/2023 09:05:33 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 01/31/2023 09:05:13 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 01/31/2023 09:04:43 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 01/31/2023 09:04:15 PM
- Amended Statement of Ownership (sc 13g/a) • Edgar (US Regulatory) • 01/31/2023 06:59:42 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 01/25/2023 01:01:38 PM
- FDA Accepts Intercept’s New Drug Application for OCA for the Treatment of Pre-Cirrhotic Liver Fibrosis Due to NASH • GlobeNewswire Inc. • 01/19/2023 01:00:00 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 01/17/2023 01:01:39 PM
FEATURED Tiziana Life Sciences Announces Anti-CD3 mAb Research for the Treatment of Alzheimer's Disease to be Presented by Dr. Howard Weiner at the International Conference on Alzheimer's and Parkinson's Disease and Related Neurological Disorders Conference • Mar 31, 2023 7:07 AM
ILUS Confirms Further Funding Arrangements and Note Settlement • ILUS • Mar 31, 2023 10:21 AM
Sigyn Therapeutics Announces Filing of 2022 Annual Report on SEC Form 10-K • SIGY • Mar 31, 2023 10:06 AM
ARway Secures Multiple New SDK Deals to Drive Growth in $44B Indoor Positioning and Navigation Market • ARWYF • Mar 30, 2023 10:30 AM
Nextech3D.ai Enters Asian Market with Major 3D Modeling Deal to Revolutionize E-Commerce • NTAR • Mar 30, 2023 10:00 AM
OMID Posts 2022 Annual Report and Provides Update • OMID • Mar 30, 2023 9:15 AM